On Friday, 18 November, the European Commission announced that the Health Emergency Preparedness and Response Authority (HERA) had signed a joint procurement framework contract with biotechnology company Bavarian Nordic A/S for the delivery of Imvanex, a third-generation monkeypox vaccine (see EUROPE B12998A24).
The framework contract provides participating countries the option to receive delivery of up to 2 million doses of monkeypox vaccine in 2023 and 2024. The European Commission...